Therefore, the inactivation of GSK3-β may be an important neuroprotective factor in Alzheimer’s disease, since activated GSK3 affects β-amyloid metabolism and tau protein phosphorylation. This evidence concerns the gene GSK3B and early-onset autosomal dominant Alzheimer disease.